Absci(ABSI.US)

Last Updated 19:00:00 ET
longbridge loading

Absci to present at Jefferies Global Healthcare Conference

PUBT·
US
ABSI
+5.40%
US
IBB
+1.46%
US
PBE
+0.89%
PUBT·
US
ABSI
+5.40%
US
IBB
+1.46%
US
PBE
+0.89%

HC Wainwright Has Optimistic Outlook of Absci Q3 Earnings

Market Beat·
US
ABSI
+5.40%
Market Beat·
US
ABSI
+5.40%

AbSci (ABSI) Receives a Rating Update from a Top Analyst

Tip Ranks·
US
ABSI
+5.40%
US
LABU
+8.35%
US
PBE
+0.89%
Tip Ranks·
US
ABSI
+5.40%
US
LABU
+8.35%
US
PBE
+0.89%

AbSci Price Target Raised to $11 as Analyst Reiterates Buy on Promising PRLR Pipeline and ABS-201 Data

Tip Ranks·
US
ABSI
+5.40%
US
SBIO
+2.81%
US
PBE
+0.89%
Tip Ranks·
US
ABSI
+5.40%
US
SBIO
+2.81%
US
PBE
+0.89%

Absci Corp. Charts High-Stakes Path With ABS-201

Tip Ranks·
US
ABSI
+5.40%
US
IBBQ
+1.65%
US
BBH
+0.22%
Tip Ranks·
US
ABSI
+5.40%
US
IBBQ
+1.65%
US
BBH
+0.22%

12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga_article·
US
INM
-0.25%
US
AMLX
+2.16%
US
SRTS
-0.75%
benzinga_article·
US
INM
-0.25%
US
AMLX
+2.16%
US
SRTS
-0.75%

Absci shares are trading lower after the company reported mixed Q1 financial results.

benzinga_article·
US
ABSI
+5.40%
benzinga_article·
US
ABSI
+5.40%

Brendan Smith Reiterates Buy on AbSci, Citing Emerging PRLR Franchise and Multiple Upcoming Clinical Catalysts

Tip Ranks·
US
ABSI
+5.40%
US
XBI
+2.77%
US
IBBQ
+1.65%
Tip Ranks·
US
ABSI
+5.40%
US
XBI
+2.77%
US
IBBQ
+1.65%

Absci | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 215 K

Earnings Watch·
US
ABSI
+5.40%
Earnings Watch·
US
ABSI
+5.40%
© 2026 Longbridge｜Disclaimer